NEXT GENERATION HEALTH LIMITEDActive

Company number 05336121Private limited companyIncorporated 2005

Key figures

£503,262+0.0%
Net assets 2024/25
+0.0%
Average annual growth 2021/22–2024/25
0200 k400 k600 k2021/222022/232023/242024/25

NEXT GENERATION HEALTH LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Profit for the year225,605575,1480279,500
Total assets————
Total liabilities———261
Net assets / total equity503,262503,262503,262503,262
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company and group continued to be that of retail pharmacy and dispensing chemists.

As described in the company's latest filed accounts.

Summary: NEXT GENERATION HEALTH LIMITED

Company

NEXT GENERATION HEALTH LIMITED is a private limited company registered with Companies House under company number 05336121. It was incorporated on 18 Jan 2005. Its status is active. The registered office is in Chester (CH1). Its nature of business (SIC 2007) is non-trading company (74990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files group accounts. Profit for the year was £279,500. Net assets were £503,262, up 0% on the previous year. The company had an average of 0 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

2 persons with significant control are registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 1 Jan 2027.